Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic and immunological role of cuproptosis-related protein FDX1 in pan-cancer

19 Aug 2022

Abstract excerpt

Background: Cancer is the second cause of death worldwide. Copperoptosis is a new mode of regulated cell death and is strongly associated with metabolic pathways. FDX1 is a key gene that promotes copperoptosis, and its impact on tumor pathogenesis and tumor immune response is indistinct and needs further exploration. Methods: Data was mined from the Cancer Genome Atlas database, the Broad Institute Cancer Cell...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ferroptosis and cancer prognosis
Share to MicroRNA in disease regulation
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36061184
DOI: 10.3389/fgene.2022.962028

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic and immunological role of cuproptosis-related protein FDX1 in pan-cancerPMID 36061184Read ↗

Pan-cancer analyses confirmed the cuproptosis-related gene FDX1 as an immunotherapy predictor and prognostic biomarkerSemantic proximity Read ↗

Pan-cancer analysis of potential biological function and prognostic value of copper homeostasis related gene ferredoxin-1Semantic proximity Read ↗

Pan-cancer integrated bioinformatics analysis reveals cuproptosis related gene FDX1 is a potential prognostic and immunotherapeutic biomarker for lower-grade gliomasSemantic proximity Read ↗

Ferredoxin 1 is a cuproptosis-key gene responsible for tumor immunity and drug sensitivity: A pan-cancer analysisSemantic proximity Read ↗

Characterization of the functional effects of ferredoxin 1 as a cuproptosis biomarker in cancerSemantic proximity Read ↗

A Pan-Cancer Analysis of prognosis and immunity of cuproptosis-related gene FDX1Semantic proximity Read ↗

Pan-cancer analysis reveals the value of FDX1 as a novel biomarker in the prognosis and immunotherapy in human tumorsSemantic proximity Read ↗

Prognostic and immunological role of FDX1 in pan-cancer: an in-silico analysisSemantic proximity Read ↗

Multi-omics pan-cancer study of cuproptosis core gene FDX1 and its role in kidney renal clear cell carcinomaSemantic proximity Read ↗

Molecular Function Validation and Prognostic Value Analysis of the Cuproptosis-Related Gene Ferredoxin 1 in Colon CancerSemantic proximity Read ↗

Balancing between cuproplasia and copper-dependent cell death: molecular basis and clinical implications of ATOX1 in cancerSemantic proximity Read ↗

Pan-cancer patterns of cuproptosis markers reveal biologically and clinically relevant cancer subtypesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.